Second Sight Medical Products, Inc.
If you purchased Second Sight Medical Products, Inc. securities and would like to join the action, please click "Join This Action" below.
EYES STOCK INVESTIGATION: HALPER SADEH LLP IS INVESTIGATING WHETHER THE MERGER OF SECOND SIGHT MEDICAL PRODUCTS, INC. IS FAIR TO SHAREHOLDERS
February 9, 2022.
New York, NY—Halper Sadeh LLP, an investor rights law firm, is investigating whether the merger of Second Sight Medical Products, Inc. (NASDAQ: EYES) and Nano Precision Medical, Inc. is fair to Second Sight shareholders.
The investigation concerns whether Second Sight and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Second Sight shareholders; and (2) disclose all material information necessary for Second Sight shareholders to adequately assess and value the merger consideration. On behalf of Second Sight shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLP represents investors worldwide who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.